Tower Research Capital (TRC)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
|
|||||
|
2025
Q1 | $259K | Sell |
|
|||||
|
2024
Q4 | $570K | Buy |
|
|||||
|
2024
Q3 | $53.4K | Sell |
|
|||||
|
2024
Q2 | $852K | Buy |
|
|||||
|
2024
Q1 | $40.4K | Sell |
|
|||||
|
2023
Q4 | $332K | Buy |
|
|||||
|
2023
Q3 | $52.4K | Sell |
|
|||||
|
2023
Q2 | $244K | Buy |
|
|||||
|
2023
Q1 | $72K | Sell |
|
|||||
|
2022
Q4 | $50K | Sell |
|
|||||
|
2022
Q3 | $167K | Sell |
|
|||||
|
2022
Q2 | $298K | Buy |
|
|||||
|
2022
Q1 | $179K | Buy |
|
|||||
|
2021
Q4 | $275K | Buy |
|
|||||
|
2021
Q3 | $554K | Buy |
|
|||||
|
2021
Q2 | $326K | Sell |
|
|||||
|
2021
Q1 | $467K | Buy |
|
|||||
|
2020
Q4 | $176K | Sell |
|
|||||
|
2020
Q3 | $127K | Sell |
|
|||||
|
2020
Q2 | $775K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $38K | Buy |
|
|||||
|
2019
Q3 | $10K | Buy |
|